|
The FDA Panel will be reviewing a competitor's opthalmic (eye) drug on Friday, June 26th. If the Panel recommends the drug for approval and if it is eventually approved, the drug could take a sizable bit out of ACL's revenues. To read about our opinon on the FDA Panel's upcoming outcome, the drug, the disease, the market, and the competitors, get a FREE report at: http://www.newbiomedicine.com
Sentiment : Strong Buy Rating :
 (No ratings) |
 |
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
Messages in Topic
| Subject | Author | Rating | Time of Post (ET) | ||
|---|---|---|---|---|---|
|
Upcoming FDA Panel recommendation on June 26th of a sma...
|
dasamrita83 | Not rated | 24-Jun-09 08:52 am | ||
|
...
|
genesisluke...
Online Now
|
Rate it | 25-Oct-09 01:10 pm |
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
1.03